Stay updated on AK102 in HeFH: PCSK9 Inhibitor Clinical Trial
Sign up to get notified when there's something new on the AK102 in HeFH: PCSK9 Inhibitor Clinical Trial page.

Latest updates to the AK102 in HeFH: PCSK9 Inhibitor Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.3.3 was added and references to HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedThe changes are updates to the record history (Revision: v3.3.2 and v3.2.0) affecting only page metadata. They do not modify study details such as eligibility, outcomes, or recruitment; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedRemoved the site-wide government funding notice about updates possibly not being up to date. This banner did not affect the trial record or its history.SummaryDifference0.8%

- Check63 days agoChange DetectedVersion 2023-03-01 adds an update to the Recruitment Status in the study record for NCT04173793.SummaryDifference0.1%

- Check92 days agoChange DetectedUpdated operating status notice and version to v3.2.0; removes v3.1.0.SummaryDifference13%

- Check99 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or update a. No changes to core content, pricing, or stock are evident.SummaryDifference0.3%

Stay in the know with updates to AK102 in HeFH: PCSK9 Inhibitor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK102 in HeFH: PCSK9 Inhibitor Clinical Trial page.